Federated Hermes
ABVX

Federated Hermes’s Abivax ABVX Stock Holding History

Federated Hermes’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4M Sell
77,900
-30,300
-28% -$3.43M 0.01% 685
2026
Q1 		$12M Hold
108,200
– – 0.02% 585
2025
Q4 		$14.6M Buy
108,200
+8,700
+9% +$949K 0.02% 528
2025
Q3 		$8.45M Buy
+99,500
New +$6.1M 0.01% 603

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Federated Hermes's ABVX Position: Q2 2026 in Review

Federated Hermes reduced its Abivax (ABVX) stake by 28% in Q2 2026, selling an estimated $3.43M and leaving 77,900 shares worth $10.4M. The position accounts for 0.01% of the portfolio, ranked #685.

Federated Hermes first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. The position peaked at $14.6M in Q4 2025. 303 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Federated Hermes held 77,900 shares of Abivax worth $10.4M as of Q2 2026.
  • Federated Hermes sold 30,300 Abivax shares in Q2 2026, an estimated $3.43M.
  • Abivax made up 0.01% of Federated Hermes's portfolio in Q2 2026, its #685 holding.
  • Federated Hermes first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • Federated Hermes's Abivax position peaked at $14.6M in Q4 2025.
  • 303 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.